Fortrea Holdings Inc.

FTRE · Nasdaq · SIC 8071: Services-Medical Laboratories
52
SEC Filings

Business Summary

PART I Overview Fortrea Holdings Inc. is a leading global contract research organization (CRO), providing biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology and medical device customers. We provide phase I through IV clinical trial management, clinical pharmacology, and consulting services for our customers. For more than 30 years, we have supported our global pharmaceutical, biotechnology, and medical device customers across more than 20 therapeu...

Next Earnings

Q2 FY2026 — expected 2026-09-15

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionFTREdiscussed_in_filing Artificial Intelligence
topic_mentionFTREdiscussed_in_filing Cybersecurity
topic_mentionFTREdiscussed_in_filing Trusted Computing
topic_mentionFTREdiscussed_in_filing Blockchain & Crypto
topic_mentionFTREdiscussed_in_filing Supply Chain
topic_mentionFTREdiscussed_in_filing Regulation
topic_mentionFTREdiscussed_in_filing Healthcare & Bio
topic_mentionFTREdiscussed_in_filing Artificial Intelligence
topic_mentionFTREdiscussed_in_filing Cybersecurity
topic_mentionFTREdiscussed_in_filing Trusted Computing
topic_mentionFTREdiscussed_in_filing Blockchain & Crypto
topic_mentionFTREdiscussed_in_filing Supply Chain
topic_mentionFTREdiscussed_in_filing Regulation
topic_mentionFTREdiscussed_in_filing Healthcare & Bio
topic_mentionFTREdiscussed_in_filing Artificial Intelligence
topic_mentionFTREdiscussed_in_filing Cybersecurity
topic_mentionFTREdiscussed_in_filing Trusted Computing
topic_mentionFTREdiscussed_in_filing Blockchain & Crypto
topic_mentionFTREdiscussed_in_filing Supply Chain
topic_mentionFTREdiscussed_in_filing Regulation

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001628280-26-012244EDGAR69K words
2025-03-032024-12-310001965040-25-000015EDGAR—
2024-03-132023-12-310001965040-24-000010EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001628280-25-049522EDGAR20K words
2025-08-062025-06-300001965040-25-000050EDGAR—
2025-05-122025-03-310001965040-25-000027EDGAR—
2024-11-082024-09-300001965040-24-000064EDGAR—
2024-08-122024-06-300001965040-24-000054EDGAR—
2024-05-242024-03-310001965040-24-000036EDGAR—
2023-11-132023-09-300001965040-23-000043EDGAR—
2023-08-142023-06-300001965040-23-000030EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-260001628280-26-011942EDGAR5K words
2025-11-200001628280-25-053390EDGAR—
2025-11-050001628280-25-049217EDGAR—
2025-09-220001628280-25-042341EDGAR—
2025-08-270001965040-25-000088EDGAR—
2025-08-060001965040-25-000048EDGAR—
2025-06-120001965040-25-000036EDGAR—
2025-06-120001193125-25-139600EDGAR—
2025-06-110001193125-25-139161EDGAR—
2025-05-120001965040-25-000023EDGAR—

52 total filings indexed. 31 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

AMS — AMERICAN SHARED HOSPITAL SERVICES ACON — Aclarion, Inc. ADVB — Advanced Biomed Inc. BDSX — BIODESIX INC BLLN — BillionToOne, Inc. BGLC — BioNexus Gene Lab Corp CSTL — CASTLE BIOSCIENCES INC CFOR — CapForce Inc.

Company Identity

CIK0001965040
TickerFTRE
ExchangeNasdaq
SIC8071: Services-Medical Laboratories

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 204ade88f6b2c65c8aaa06d9b3efcbca389dd4603c8b9eed57377d1fadc6930d
parent: f7b6ee3416a955e1cb21e559117ea0dd5399e7b857d056ed32486b4033f46853
content hash: 877353df9dac37db8419b2f356405e4b75ec2de7186edfd598ff7a773a7f0662
signed: 2026-04-13T04:45:09.669Z
sources: 11 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf